Ephrin receptor A2 is a functional entry receptor for Epstein-Barr virus.

Nature Microbiology
Jia ChenRichard Longnecker


Epstein-Barr virus (EBV) is an oncogenic virus that infects more than 90% of the world's population 1 . EBV predominantly infects human B cells and epithelial cells, which is initiated by fusion of the viral envelope with a host cellular membrane 2 . The mechanism of EBV entry into B cells has been well characterized 3 . However, the mechanism for epithelial cell entry remains elusive. Here, we show that the integrins αvβ5, αvβ6 and αvβ8 do not function as entry and fusion receptors for epithelial cells, whereas Ephrin receptor tyrosine kinase A2 (EphA2) functions well for both. EphA2 overexpression significantly increased EBV infection of HEK293 cells. Using a virus-free cell-cell fusion assay, we found that EphA2 dramatically promoted EBV but not herpes simplex virus (HSV) fusion with HEK293 cells. EphA2 silencing using small hairpin RNA (shRNA) or knockout by CRISPR-Cas9 blocked fusion with epithelial cells. This inhibitory effect was rescued by the expression of EphA2. Antibody against EphA2 blocked epithelial cell infection. Using label-free surface plasmon resonance binding studies, we confirmed that EphA2 but not EphA4 specifically bound to EBV gHgL and this interaction is through the EphA2 extracellular domain (ECD). Th...Continue Reading


Jul 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·J D FingerothD T Fearon
Jun 1, 1997·Journal of Virology·Q LiLindsey M Hutt-Fletcher
Jan 7, 1998·Journal of Virology·X Wang, Lindsey M Hutt-Fletcher
Feb 28, 2002·Molecular Cell·Maureen M MullenTheodore S Jardetzky
Feb 20, 2003·Nature Medicine·Sharof M TugizovJoel M Palefsky
Jan 15, 2005·Cancer Science·Ritsuko NakamuraHaruhiko Sugimura
Feb 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Marija BackovicTheodore S Jardetzky
Nov 19, 2009·Proceedings of the National Academy of Sciences of the United States of America·Liudmila S ChesnokovaLindsey M Hutt-Fletcher
Dec 15, 2010·Proceedings of the National Academy of Sciences of the United States of America·Hisae MatsuuraTheodore S Jardetzky
Apr 12, 2011·Nature Reviews. Microbiology·Sarah A ConnollyRichard Longnecker
Jun 8, 2012·Nature Medicine·Chris Boshoff
Jan 10, 2013·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·Zhe ShaoZhengjun Shang
Aug 22, 2014·PLoS Pathogens·Karthik SathiyamoorthyTheodore S Jardetzky
Jan 23, 2016·Nature Reviews. Molecular Cell Biology·Artur Kania, Rüdiger Klein
Dec 9, 2016·Nature Communications·Karthik SathiyamoorthyTheodore S Jardetzky


Mar 22, 2018·Cancers·Kathy H Y ShairVaughn S Cooper
Feb 2, 2018·Viruses·Makda GebreBenjamin E Gewurz
Aug 21, 2018·Annual Review of Pathology·Paul J Farrell
Jan 17, 2019·FEMS Microbiology Reviews·Blossom Damania, Christian Münz
Jan 16, 2018·Nature Reviews. Microbiology·Andrea Du Toit
Sep 4, 2019·Nature Reviews. Microbiology·Christian Münz
Jan 31, 2020·PLoS Pathogens·Thayer K DarlingTracey J Lamb
Apr 3, 2020·Journal of Virology·Nicholas A SmithRosemary Rochford
Oct 5, 2019·FEMS Microbiology Reviews·Jia Chen, Richard Longnecker
Jul 26, 2018·Cellular and Molecular Life Sciences : CMLS·Makeda RobinsonShirit Einav
Mar 13, 2019·Frontiers in Oncology·Dwain G van ZylHenri-Jacques Delecluse
Apr 17, 2020·Journal of Virology·Jingjing MaHuamin Tang
Jul 24, 2019·Frontiers in Immunology·Thayer K Darling, Tracey J Lamb
Mar 14, 2019·Frontiers in Microbiology·Kiem VuAngie Gelli
Jan 2, 2020·Cellular and Molecular Life Sciences : CMLS·Jia WangZailong Qin
Mar 21, 2019·Scientific Reports·Natalia Bravo-SantanoMichal Letek
Jun 26, 2020·Infectious Agents and Cancer·Valli De ReMaurizio Mascarin
Nov 27, 2019·International Journal of Molecular Sciences·Lilit TonoyanAlain Doglio
Nov 26, 2020·Nature Communications·Chao SuJinghua Yan
Jan 14, 2021·Journal of Biomolecular Structure & Dynamics·Shweta JakhmolaHem Chandra Jha
Nov 26, 2020·Molecular Therapy : the Journal of the American Society of Gene Therapy·Garima SharmaChiranjib Chakraborty
Jan 26, 2021·Frontiers in Immunology·Gunnar Houen, Nicole Hartwig Trier
Oct 23, 2020·Nature Reviews. Microbiology·Sarah A ConnollyRichard Longnecker
Jan 1, 2019·Current Clinical Microbiology Reports·Darin J Weed, Blossom Damania
Mar 7, 2021·Cancers·Alison J SinclairThomas Amoaten

Datasets Mentioned


Methods Mentioned

flow cytometry
surface plasmon resonance
gel filtration

Related Concepts

Related Feeds

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

Virology & CRISPR

This feed focuses on the virology of CRISPR and its use in developing CRISPR-Cas systems. Discover the latest research here.

CRISPRi Screens for Antibiotics

The CRISPR-Cas system is a gene editing technique that can be used for high-throughput genome-wide screens to identify modes of actions of novel antibiotics. Here is the latest research.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.